EDITORIAL: Roche's cold feet can only frustrate JWT

Just when Roche appeared ready to be led gently out of Bates into J. Walter Thompson's arms, the drugs company appears to be having second thoughts. Nothing wrong with that, of course. Frustrating as it is for those charged with managing the smooth transfer of such accounts, some clients will resent any suggestion that they should follow others after a change of ownership.